ECSP099308A - Métodos de tratamiento de la depresión - Google Patents

Métodos de tratamiento de la depresión

Info

Publication number
ECSP099308A
ECSP099308A EC2009009308A ECSP099308A ECSP099308A EC SP099308 A ECSP099308 A EC SP099308A EC 2009009308 A EC2009009308 A EC 2009009308A EC SP099308 A ECSP099308 A EC SP099308A EC SP099308 A ECSP099308 A EC SP099308A
Authority
EC
Ecuador
Prior art keywords
formula
depression
treatment
methods
present
Prior art date
Application number
EC2009009308A
Other languages
English (en)
Inventor
Magali Haas
Yong Moon Choi
Robert Gordon
Ewa Malatynska
Original Assignee
Janssen Pharmaceutica Nv
Sk Holdings
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39167608&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ECSP099308(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Janssen Pharmaceutica Nv, Sk Holdings filed Critical Janssen Pharmaceutica Nv
Publication of ECSP099308A publication Critical patent/ECSP099308A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invención es un método de tratamiento de la depresión, que comprende administrar a un sujeto en necesidad del mismo una cantidad terapéuticamente efectiva de uno o más compuestos de carbamato de fórmula 1 y/o de fórmula 2, como aquí se define y se muestra mas abajo:Fórmula 1Fórmula 2La presente invención está dirigida a un método de tratamiento de la depresión, que incluye monoterapia y alternativamente coterapia con al menos un antidepresivo adicional.
EC2009009308A 2006-10-30 2009-04-30 Métodos de tratamiento de la depresión ECSP099308A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US86340806P 2006-10-30 2006-10-30

Publications (1)

Publication Number Publication Date
ECSP099308A true ECSP099308A (es) 2009-10-30

Family

ID=39167608

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2009009308A ECSP099308A (es) 2006-10-30 2009-04-30 Métodos de tratamiento de la depresión

Country Status (22)

Country Link
US (1) US20080317883A1 (es)
EP (1) EP2081648A2 (es)
JP (1) JP2010508355A (es)
KR (1) KR20090110889A (es)
CN (1) CN101568362A (es)
AR (1) AR064241A1 (es)
AU (1) AU2007313865A1 (es)
BR (1) BRPI0718324A2 (es)
CA (1) CA2667949A1 (es)
CL (1) CL2007003120A1 (es)
EA (1) EA200970436A1 (es)
EC (1) ECSP099308A (es)
IL (1) IL198484A0 (es)
MX (1) MX2009004770A (es)
NI (1) NI200900073A (es)
NO (1) NO20092018L (es)
PE (1) PE20080929A1 (es)
SV (1) SV2009003247A (es)
TW (1) TW200835477A (es)
UY (1) UY30675A1 (es)
WO (1) WO2008055022A2 (es)
ZA (1) ZA200903771B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9018253B2 (en) 2010-07-02 2015-04-28 Bio-Pharm Solutions Co., Ltd. Phenylcarbamate compound and muscle relaxant containing the same
US8609849B1 (en) 2010-11-30 2013-12-17 Fox Chase Chemical Diversity Center, Inc. Hydroxylated sulfamides exhibiting neuroprotective action and their method of use
CA2815460C (en) 2011-01-13 2017-04-18 Bio-Pharm Solutions Co., Ltd. Process for preparation of phenyl carbamate derivatives
KR101795562B1 (ko) 2011-12-27 2017-11-08 (주)바이오팜솔루션즈 뇌졸중의 치료 또는 예방에 사용되는 페닐카바메이트 화합물
US11202800B1 (en) * 2013-02-26 2021-12-21 Jeanne Fleming Methods for treating emotional cognitive disconnect
JP6131341B2 (ja) * 2013-03-12 2017-05-17 バイオ−ファーム ソリューションズ カンパニー リミテッド フェニルカルバメート化合物及びこれを含む精神疾患の予防又は治療用組成物｛ｐｈｅｎｙｌｃａｒｂａｍａｔｅｃｏｍｐｏｕｎｄａｎｄａｃｏｍｐｏｓｉｔｉｏｎｆｏｒｐｒｅｖｅｎｔｉｎｇｏｒｔｒｅａｔｉｎｇａｐｓｙｃｈｉａｔｒｉｃｄｉｓｏｒｄｅｒｃｏｍｐｒｉｓｉｎｇｔｈｅｓａｍｅ｝
CN109939092B (zh) 2013-03-12 2022-03-22 比皮艾思药物研发有限公司 用于预防或治疗小儿癫痫和癫痫相关综合征的苯基氨基甲酸酯化合物
CN116478225B (zh) * 2023-04-12 2024-06-11 南京工业大学 一种丝氨酸改性的虫草素磷酸酯药物分子的制备方法与应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3313692A (en) * 1958-04-21 1967-04-11 Armour Pharma Method of inducing calming and muscle relaxation with carbamates
US3265728A (en) * 1962-07-18 1966-08-09 Armour Pharma Substituted phenethyl carbamates
US5698588A (en) * 1996-01-16 1997-12-16 Yukong Limited Halogen substituted carbamate compounds from 2-phenyl-1,2-ethanediol
US20030027817A1 (en) * 1998-05-29 2003-02-06 Tollefson Gary Dennis Combination therapy for treatment of bipolar disorders
CZ20032300A3 (cs) * 2001-02-27 2005-01-12 Ortho-Mcneil Pharmaceutical, Inc. Léčivo pro prevenci nebo léčbu bipolárních chorob
HUP0303261A3 (en) * 2001-02-27 2012-07-30 Ortho Mcneil Pharm Inc Carbamate compounds for use in preventing or treating bipolar disorder
IL157591A0 (en) * 2001-02-27 2004-03-28 Ortho Mcneil Pharm Inc Carbamate compounds for use in preventing or treating neurodegenerative disorders
DE60216457T2 (de) * 2001-02-27 2007-09-20 Ortho-Mcneil Pharmaceutical, Inc. Carbamate verbindungen zur behandlung oder verhutung von psychotischen krankheiten
KR20070083826A (ko) * 2004-10-28 2007-08-24 에스케이 주식회사 우울증을 위한 부가 요법

Also Published As

Publication number Publication date
ZA200903771B (en) 2010-08-25
MX2009004770A (es) 2009-08-17
CL2007003120A1 (es) 2008-07-18
UY30675A1 (es) 2008-05-02
IL198484A0 (en) 2011-08-01
NI200900073A (es) 2010-02-25
US20080317883A1 (en) 2008-12-25
AR064241A1 (es) 2009-03-25
WO2008055022A3 (en) 2008-06-19
SV2009003247A (es) 2009-11-24
CA2667949A1 (en) 2008-05-08
NO20092018L (no) 2009-05-26
WO2008055022A2 (en) 2008-05-08
EP2081648A2 (en) 2009-07-29
CN101568362A (zh) 2009-10-28
AU2007313865A1 (en) 2008-05-08
JP2010508355A (ja) 2010-03-18
EA200970436A1 (ru) 2009-12-30
BRPI0718324A2 (pt) 2013-11-26
KR20090110889A (ko) 2009-10-23
PE20080929A1 (es) 2008-07-19
TW200835477A (en) 2008-09-01

Similar Documents

Publication Publication Date Title
ECSP088762A (es) Tratamiento del dolor
NI200900074A (es) Tratamiento de los trastornos generalizados del desarrollo
ATE502633T1 (de) Cyclosporins zur behandlung und vorbeugung von augenerkrankungen
CR10165A (es) "uso de derivados de sulfamida heterociclo benzo-fusionado para el tratamiento de depresión"
CR11510A (es) Uso de un inhibidor de la gamma-secretasa para tratamiento del cancer
NI200900073A (es) Compuestos de carbamato para su uso en el tratamiento de la depresión.
ECSP12011880A (es) INHIBIDORES DE N1-PIRAZOLOESPIROCETONA ACETIL-CoA CARBOXILASA
MA32784B1 (fr) Composes aryles substitues par heterocycle comme inhibiteurs de hif
EA201071038A1 (ru) Производные 1-бензил-3-гидроксиметилиндазола и их применение для лечения заболеваний, основанных на экспрессии mcp-1, cx3cr1 и p40
CR9601A (es) Composiciones y metodos para el tratamiento de sintomas relacionados con el ciclo
NI200800169A (es) Uso de derivados de sulfamidas heterocíclicas benzo-fusionadas para el tratamiento del dolor
EA201170425A1 (ru) Тетрациклиновые соединения для лечения ревматоидного артрита и связанные с ними способы лечения
BRPI0908635A8 (pt) composto, composição farmacêutica e método de tratamento de câncer
EA201071043A1 (ru) Новые производные 1-бензил-3-гидроксиметилиндазола и их применение при лечении заболеваний, обусловленных экспрессией mcp-1 и cx3cr1
CY1115690T1 (el) Συνθεσεις βασιζομενες σε arthrospirα και χρησεις αυτων
EA201391486A1 (ru) Способы и композиции для лечения болезни паркинсона
EA201070250A1 (ru) Противомикробный парентеральный состав
UY30158A1 (es) Uso de derivados de benzo-heteroaril sulfamida para el tratamiento del dolor
UA107562C2 (uk) Спосіб лікування псоріазу
NZ597866A (en) Therapeutic lactams
EA200970425A1 (ru) Способы лечения расстройств, выражающихся в разрушительном поведении
EA201070496A1 (ru) УГЛЕРОД-СВЯЗАННЫЕ МОДУЛЯТОРЫ γ-СЕКРЕТАЗЫ
EA201071350A1 (ru) Композиции и способы для лечения воспаления роговицы
MA31992B1 (fr) Nouvel usage medical des sels de 3-(2,2,2-trimethylhydrazinium) propionate
EA200701584A1 (ru) Органические соединения, применяемые для лечения болезни альцгеймера, их применение и способ получения